Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of NEUROCUPLE™ as an Alternative to Opioids Following Total Knee Arthroplasty Patients

NCT07439666 is registered in ClinicalTrials.gov with Jacques E. Chelly as lead sponsor.

NCT NCT07439666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07439666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of NEUROCUPLE™ as an Alternative to Opioids Following Total Knee Arthroplasty Patients
Lead sponsor
Jacques E. Chelly
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
November 30, 2027
Enrollment
274 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

opioid reduction after tka, total knee arthroplasty postoperative pain